Debbie Pierce
Psychiatric/Mental Health · Covington, LANPI 1235744608
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 432 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 25.1% of the total. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 432 payments — averaging $15.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Axsome Therapeutics, Inc.$673
- Teva Pharmaceuticals USA, Inc.$557
- Alkermes, Inc.$547
- Sunovion Pharmaceuticals Inc.$501
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$491
- plus $2K from 14 others
What the payments were for
- Food & beverage$6,75798%
- Education$1382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 115 | $1,733 |
| Axsome Therapeutics, Inc. | 36 | $673 |
| Teva Pharmaceuticals USA, Inc. | 37 | $557 |
| Alkermes, Inc. | 31 | $547 |
| Sunovion Pharmaceuticals Inc. | 37 | $501 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $491 |
| Lundbeck LLC | 30 | $458 |
| Vanda Pharmaceuticals Inc. | 19 | $442 |
| Otsuka America Pharmaceutical, Inc. | 23 | $423 |
| Supernus Pharmaceuticals, Inc. | 16 | $277 |
| Neurocrine Biosciences, Inc. | 10 | $229 |
| E.r. Squibb & Sons, L.L.C. | 11 | $207 |
| Indivior Inc. | 7 | $122 |
| Johnson & Johnson | 6 | $108 |
| Tris Pharma Inc | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Pfizer | 1 | $16 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
| Braeburn Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $11 |
How this compares
$6,895 in reported general payments places this provider in the 90th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 31 | $106,123 |
| RexultiBrexpiprazole | 39 | $81,332 |
| VraylarCariprazine Hcl | 42 | $63,157 |
| CaplytaLumateperone Tosylate | 37 | $59,482 |
| SecuadoAsenapine | 20 | $26,912 |
| Risperdal ConstaRisperidone Microspheres | 12 | $20,558 |
| Paliperidone ErPaliperidone | 23 | $3,105 |
| Risperidone | 137 | $1,686 |
| Oxcarbazepine | 70 | $1,541 |
| Zolpidem Tartrate | 12 | $1,082 |
| Ramelteon | 11 | $875 |
| Escitalopram Oxalate | 90 | $844 |
| Divalproex Sodium | 71 | $825 |
| Aripiprazole | 66 | $763 |
| Trazodone Hcl | 92 | $600 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $108 | $126,68143 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $423 | $81,33239 claims |
| AbbVieVraylar | $1,733 | $63,15742 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $491 | $59,48237 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Covington
- Hali MillerCovington$8K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.